Thalidomide neurotoxicity in dermatological patients: The next "STEP"

Journal of Investigative Dermatology

Volumn 119, Issue 5, 2002, Pages 987-988

  Gaspari, Anthony ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

THALIDOMIDE; THALIDOMIDE DERIVATIVE;

CARDIOVASCULAR RISK; CLINICAL FEATURE; DOSE RESPONSE; DRUG SAFETY; DRUG USE; HUMAN; NEUROTOXICITY; NOTE; PATIENT MONITORING; PATIENT SELECTION; PERIPHERAL NEUROPATHY; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; RISK ASSESSMENT; SKIN DISEASE;

EID: 0036443681     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2002.19538.x     Document Type: Note

References (8)

1. Corral LG, Kaplan G: Immunomodulation by thalidomide and thalidomide analogues. Ann Rheum Ds 58:1107-1113, 1999
2. Fullerton PM, O'Sullivan DJ: Thalidomide neuropathy. A clinical electrophysiological, and histological follow-up study. J Neurol Neurosurg Psychiatry 31:543-551, 1968
3. Herranz P, Pizarro A, DeLucus R, et al: Treatment of AIDS-associated prurigo nodularis with thalidomide. Clin Exp Dermatol 23:233, 1998
4. Hess CW, Hunziker T, Kupfer A, Ludin HP: Thalidomide-induced peripheral neuropathy. A prospective clinical, neurophysiological and pharmacogenetic evaluation. J Neurol 223:83-89, 1986
5. Knop J, Bonsmann G, Happle R, Ludolph A, Matz DR, Mifsud EJ, Macher E: Thalidomide in the treatment of sixty cases of chronic discoid lupus erythematosus. Br J Dermatol 108:461-466, 1983
6. Lagueny A, Rommel A, Vignolly B, et al: Thalidomide neuropathy: An electrophysiologic study. Muscle Nerve 9:837-844, 1986
7. Ochonisky S, et al: Arch. Dermatol. Thalidomide neuropathy incidence and clinicoelectrophysiological finding in 42 patients. Arch Dermatol 130:66-69, 1994
8. Tseng S, Pak G, Washenik K, Keltz Pomeranz M, Shupack J: Rediscovering thalidomide. A review of its mechanism of action, side effects and potential uses. JAAD 35:969-979, 1996